Ginkgo provides an update on its restructuring, including achievement of its expanded $250 million cost savings targets

BOSTON , Aug. 7, 2025 /PRNewswire/ -- Ginkgo Bioworks Holdings, Inc. (NYSE: DNA, "Ginkgo"), which is building the leading platform for cell programming and biosecurity, today announced its results for the second quarter ended June 30, 2025 . The update, including a webcast slide presentation with additional details on the second quarter, as well as supplemental financial information will be available at investors.ginkgobioworks.com .

Second Quarter 2025 Financial Results

Second quarter 2025 Total revenue of $50 million , down from $56 million in the comparable prior year period

Second quarter 2025 Cell Engineering revenue of $39 million , up from

See Full Page